Avidity Partners Management LP cut its holdings in shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) by 37.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 827,010 shares of the company’s stock after selling 495,990 shares during the period. Avidity Partners Management […]